.jpg)
TSH Board of Directors Approved Financial Statements For the Nine Months Ended September 30, 2021
2021.11.3
...
.jpg)
TSH's new combo new drug has been approved and expect to get NHI price in Q2,2022. Its potentional market is approximately 2.8
2021.10.20
...
TSH Biopharm was invited to attend the online institutional investor conference hosted by IBF Securities
2021.9.27
...
.jpg)
The Company's 2021 annual general meeting approved removal of the noncompetition restrictions for directors
2021.8.20
...
.jpg)
